
CRJTF
Healthcare · Medical Instruments & Supplies · $89.2M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jun 30, 2021 | Time not confirmed | 0.00 | -0.12 | — |
| Mar 29, 2021 | After the close | 0.00 | -0.12 | — |
| Dec 10, 2020 | Before the open | 0.00 | -0.12 | — |
| Sep 18, 2020 | After the close | 0.00 | -0.11 | — |
| May 19, 2020 | After the close | 0.00 | -0.12 | — |
| Mar 26, 2020 | After the close | 0.00 | -0.12 | — |
| Dec 31, 2019 | Time not confirmed | 0.00 | -0.06 | — |
| Sep 9, 2019 | After the close | 0.00 | -0.06 | — |
| Jun 30, 2019 | Time not confirmed | 0.00 | -0.15 | — |
| Dec 31, 2018 | Time not confirmed | 0.00 | -0.32 | — |
| Sep 26, 2018 | After the close | 0.00 | -0.32 | — |
| Jun 30, 2018 | Time not confirmed | 0.00 | -0.20 | — |
| Mar 20, 2018 | Before the open | 0.00 | -0.22 | — |
Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure;…